Fingerprint
Dive into the research topics of 'Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: Results from the phase II KEYNOTE-158 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: Results from the phase II KEYNOTE-158 study
Hyun Cheol Chung, Willeke Ros, Jean Pierre Delord, Ruth Perets, Antoine Italiano, Ronnie Shapira-Frommer, Lyudmila Manzuk, Sarina A. Piha-Paul, Lei Xu, Susan Zeigenfuss, Scott K. Pruitt, Alexandra Leary
Research output: Contribution to journal › Article › peer-review
353
Citations
(Scopus)